Updated on 2025/06/16

写真a

 
Akita Takahiro
 
Affiliation
University Hospital Respiratory medicine and Infectious Diseases

Degree

  • 博士(医学)

Education

  • Hirosaki University   医学研究科

    2019.04 2024.09

      More details

    Country: Japan

  • Hirosaki University   医学部   医学科

    2012.10 2017.03

      More details

    Country: Japan

Campus Career

  • Hirosaki University   University Hospital   Respiratory medicine and Infectious Diseases   Assistant Professor  

    2025.04 Now

      More details

  • Hirosaki University   University Hospital   Emergency and Disaster Medical Center   Assistant Professor  

    2024.12 202503

      More details

  • Hirosaki University   University Hospital   Emergency and Disaster Medical Center   病院助手  

    2024.04 202411

      More details

  • Hirosaki University   University Hospital   Respiratory medicine and Infectious Diseases   医員  

    2024.02 202403

      More details

  • Hirosaki University   University Hospital   Respiratory medicine and Infectious Diseases   医員  

    2019.12 202003

      More details

  • Hirosaki University   University Hospital   Respiratory medicine and Infectious Diseases   医員  

    2019.04 201909

      More details

  • Hirosaki University   University Hospital   Medical Interactiv Collaboration   研修医  

    2018.04 201903

      More details

▼display all

Research History

  • 八戸市立市民病院   呼吸器内科   医師

    2023.04 2024.01

  • がん研究会有明病院   呼吸器内科   医師

    2021.04 2023.03

  • 八戸市立市民病院   呼吸器内科   医師

    2020.10 2021.03

  • 青森県立中央病院   呼吸器内科   医師

    2020.04 2020.09

  • 弘前脳卒中・リハビリテーションセンター   医師

    2019.10 2019.11

  • 三沢市立三沢病院   研修医

    2017.04 2018.03

▼display all

Papers

  • Distinction of ALK fusion gene- and EGFR mutation-positive lung cancer with tumor markers.

    Akita T, Ariyasu R, Kakuto S, Miyadera K, Kiritani A, Tsugitomi R, Amino Y, Uchibori K, Kitazono S, Yanagitani N, Tasaka S, Nishio M.

    Thorac Cancer   2024.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Kind of work:Joint Work  

  • Efficacy of osimertinib in patients with EGFR-mutation positive non-small cell lung cancer with malignant pleural effusion.

    Kiritani A, Amino Y, Uchibori K, Akita T, Harutani Y, Ogusu S, Tsugitomi R, Manabe R, Ariyasu R, Kitazono S, Yanagitani N, Nishio M.

    Thorac Cancer.   2024.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Kind of work:Joint Work